Female mice are more susceptible to the development of allergic airway inflammation than male mice

Summary Background In humans the prevalence of asthma is higher among females than among males after puberty. The reason for this phenomenon is not clear. Objective We tested the hypothesis that female mice are more susceptible to the development of allergic asthma than male mice and studied allergi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental allergy 2005-11, Vol.35 (11), p.1496-1503
Hauptverfasser: Melgert, B. N., Postma, D. S., Kuipers, I., Geerlings, M., Luinge, M. A., van der Strate, B. W. A., Kerstjens, H. A. M., Timens, W., Hylkema, M. N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background In humans the prevalence of asthma is higher among females than among males after puberty. The reason for this phenomenon is not clear. Objective We tested the hypothesis that female mice are more susceptible to the development of allergic asthma than male mice and studied allergic immune responses in the lung. Methods We compared allergic airway inflammation, i.e. methacholine (MCh) responsiveness, serum IgE, and cytokines, and the number of the different leucocytes in lungs of male and female BALB/c mice, twice‐sensitized to ovalbumin (OVA) and subsequently challenged with OVA (OVA‐mice) or phosphate‐buffered saline (PBS‐mice) aerosols on days 24–26, 30, and 31. Results OVA challenge significantly increased MCh responsiveness, numbers of eosinophils, CD4+ T cells, CD4+/CD25+ T cells, B cells, and levels of Thelper (Th)2 cytokines, total, and OVA‐specific IgE. There was, however, also an effect of gender, with female mice responding to OVA challenges with higher numbers of eosinophils, CD4+ T cells, B cells, and levels of IL‐4, IL‐13, IFN‐γ, total, and OVA‐specific IgE than male mice. In contrast, female PBS‐mice had significantly lower percentages of regulatory CD4+/CD25+ T cells than males (females 4.2±0.2% vs. males 5.3±0.1% of CD4+ T cells, P
ISSN:0954-7894
1365-2222
DOI:10.1111/j.1365-2222.2005.02362.x